Literature DB >> 9140127

Intrinsic and extrinsic factors controlling benign prostatic growth.

C Lee1, J M Kozlowski, J T Grayhack.   

Abstract

This review will present a new concept on the etiology of the development of benign prostatic hyperplasia (BPH). Conventionally, two known etiological factors for the development of BPH have been aging and the presence of functional testes. Assignment of these two factors, although reasonable, has not been conducive to aid the research community to identify and isolate the patho-physiological agents that are directly responsible for the development of this disease. In the present review, we proposed a broadened concept of intrinsic and extrinsic factors for BPH. This concept offers identifiable research opportunities that will facilitate our quest in search for etiological agents for BPH. A brief description of various intrinsic and extrinsic factors and justifications for their selection will be discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9140127     DOI: 10.1002/(sici)1097-0045(19970501)31:2<131::aid-pros9>3.0.co;2-q

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

1.  Recent advances in the surgical treatment of benign prostatic hyperplasia.

Authors:  Bernardo Rocco; Giancarlo Albo; Rafael Coelho Ferreira; Matteo Spinelli; Gabriele Cozzi; Paolo Dell'orto; Vipul Patel; Francesco Rocco
Journal:  Ther Adv Urol       Date:  2011-12

Review 2.  Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.

Authors:  Soo Jeong Kim; Omar Al Hussein Alawamlh; Bilal Chughtai; Richard K Lee
Journal:  Curr Urol Rep       Date:  2018-08-20       Impact factor: 3.092

Review 3.  Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review.

Authors:  Matthew Ryan Macey; Mathew C Raynor
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

4.  Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.

Authors:  Koo Han Yoo; Su Kang Kim; Joo-Ho Chung; Sung-Goo Chang
Journal:  Asian J Androl       Date:  2010-06-21       Impact factor: 3.285

Review 5.  Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.

Authors:  Soum D Lokeshwar; Benjamin T Harper; Eric Webb; Andre Jordan; Thomas A Dykes; Durwood E Neal; Martha K Terris; Zachary Klaassen
Journal:  Transl Androl Urol       Date:  2019-10

6.  The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia by primary care family physicians in Portugal.

Authors:  Júlio Fonseca; Carlos Martins da Silva
Journal:  Clin Drug Investig       Date:  2015-02       Impact factor: 2.859

7.  EPN: a novel epithelial cell line derived from human prostate tissue.

Authors:  Antonio A Sinisi; Paolo Chieffi; Daniela Pasquali; Annamaria Kisslinger; Stefania Staibano; Antonio Bellastella; Donatella Tramontano
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-03       Impact factor: 2.416

Review 8.  Growth factors in benign prostatic hyperplasia: basic science implications.

Authors:  M Scott Lucia; James R Lambert
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

Review 9.  Trends in Simple Prostatectomy for Benign Prostatic Hyperplasia.

Authors:  Joseph J Pariser; Vignesh T Packiam; Melanie A Adamsky; Gregory T Bales
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

Review 10.  Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.

Authors:  Hyun Jun Park; Ji Eon Joanne Won; Sebastian Sorsaburu; Paul David Rivera; Seung Wook Lee
Journal:  World J Mens Health       Date:  2013-12-24       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.